IAP Position Paper on Burden of Mumps in India and Vaccination Strategies.
Loading...
Date
2015-06
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Justification: Mumps, despite being a widely prevalent disease in the country, is considered as an insignificant public health problem
mainly because of poor documentation of clinical cases and lack of published studies. In the absence of adequate published data on
disease burden, Government of India has recently decided to introduce measles-rubella (MR) vaccine in its National Immunization
Program and neglected mumps component.
Process: Following an IAP ACVIP meeting on December 6 and 7, 2014, a detailed review of burden of mumps in India along with
vaccination strategies to control the disease was prepared. The draft was circulated amongst the members of the committee for review
and approval. Revised final draft was later approved by IAP executive board in January 2015.
Objectives: To provide a review of community burden of mumps in India; and to discuss the vaccination strategies to impress upon
policymakers to include mumps vaccination in National immunization program.
Recommendations : A total of 14 studies and two media reports on mumps outbreak were retrieved. The outbreaks were reported from
all the regions of the country. Mumps meningoencephalitis was responsible for 2.3% to 14.6% of all investigated hospitalized acute
encephalitis syndrome or viral encephalitis cases in different studies. Data from Infectious Disease Surveillance (ID Surv) portal of IAP
and Integrated Disease Surveillance Program (IDSP) of Government of India (GoI) were also reviewed. While a total of 1052 cases were
reported by the IDSurv, IDSP had investigated 72 outbreaks with 1564 cases in 14 states during different time periods. Genotypes G
(subtype G2) and C were found to be main genotypes of the mumps virus circulating in the country. Three studies studied serological
status of young children and adolescents against mumps, and found susceptibility rates ranging from 32% to 80% in different age groups.
Conclusions: Mumps poses a significant disease burden in India. This calls for inclusion of mumps vaccine in the National immunization
program.
Description
Keywords
Epidemiology, Measles-mumps-Rubella vaccine, National immunization program, Prevention
Citation
Vashishtha Vipin M, Yadav Sangeeta, Dabas Aashima, Bansal CP, Agarwal Rohit C, Yewale Vijay N, Thacker Naveen, Kamath S S, Mehta Pravin J. IAP Position Paper on Burden of Mumps in India and Vaccination Strategies. Indian Pediatrics. 2015 June; 52(6): 505-514.